Name
Capella University
NURS-FPX 4060 Practicing in the Community to Improve Population Health
Prof. Name
Date
Community health initiatives are designed to address specific health concerns within a community, considering social, cultural, and environmental factors. These initiatives empower individuals to manage their physical, mental, social, and cultural well-being. Effective community health programs begin by assessing the needs and conditions of the population they serve (Barker et al., 2021). Various factors can contribute to recurring health issues if long-term preventive strategies are not applied. A comprehensive approach that evaluates multiple determinants of health is essential to reduce disease prevalence and enhance overall community well-being. Such initiatives often include educational programs and health literacy campaigns to raise awareness about persistent health risks (Naqvi & Gale, 2020).
One notable community health concern is Human Papillomavirus (HPV), a common sexually transmitted infection that can have serious long-term consequences.
According to the Centers for Disease Control and Prevention (CDC), approximately 19,000 women and 12,000 men in the United States are infected with HPV each year (CDC, 2021). HPV is associated with several types of cancers, including cervical, anal, oral, throat, and penile cancers. Women are disproportionately affected, with around 4,000 women dying annually due to cervical cancer. The World Health Organization (WHO) notes that men who have sex with men, individuals with multiple sexual partners, sexually abused children, and immunocompromised individuals are particularly at risk (WHO, 2023). HPV often presents asymptomatically, and visible genital warts may be the first indication of infection or cancer risk. The purpose of this plan is to develop a health promotion strategy targeting HPV prevention and awareness.
HPV is highly prevalent in the United States, with an estimated 42.5 million people currently infected (Elflein, 2023). Because the virus can remain latent for years, many individuals are unaware of their infection until symptoms or complications arise. Genital warts occur in approximately 1 in 100 individuals.
Cervical cancer affects roughly 12,000 women annually in the U.S. (CDC, 2021). Infection rates correlate with sexual activity, and women experience higher incidence rates than men. Globally, about 625,000 women and 69,000 men develop cancers associated with HPV each year (WHO, 2023).
There are over 150 types of HPV, but only a subset is considered high-risk, capable of causing genital warts or cancer. Studies indicate that women from middle- and low-income households are more susceptible to HPV infection than those from higher-income households (Galeshi et al., 2022). The diagnosis of HPV-related cancer can also have profound psychological effects, including anxiety, fear, guilt, and social stigma (Amboree & Darkoh, 2020).
Preventive strategies primarily include HPV vaccination and routine screening. Vaccinations are recommended for preteens aged 11–12 and up to age 26 for those not previously vaccinated (CDC, 2021). Individuals older than 26 should undergo regular screenings for early detection of potential cancers. Given HPV’s asymptomatic nature and its impact on physical, mental, and social health, proactive prevention measures are critical (Galeshi et al., 2022).
Common misconceptions about HPV include the belief that cancers caused by HPV are untreatable. In reality, cervical and other HPV-associated cancers can be managed and prevented through vaccinations and regular screenings. Vaccination is most effective for individuals under 26, whereas adults aged 26–45 may gain limited benefit from the vaccine (Kim et al., 2021).
Uncertainties surrounding HPV prevention include vaccination compliance rates among preteens, adolescents, and adults, the affordability of education and vaccination programs in low-income communities, and varying psychosocial impacts on individuals. Emotional and mental responses to HPV infection, such as stigma, fear, and shame, differ widely among affected individuals (Kim et al., 2021).
Cervical cancer is the fourth leading cause of cancer-related deaths among women worldwide, with over 600,000 new cases and 342,000 deaths reported in 2020 (WHO, 2022). Women from low- and middle-income communities face barriers to accessing preventive measures and treatment. Co-infections, such as HIV, increase the risk of developing cervical cancer sixfold (Clarke et al., 2021).
HPV infection is most prevalent between the ages of 15 and 25. Behavioral factors, such as multiple sexual partners and unsafe intercourse, and biological factors, including a weakened immune system, influence infection rates (Clarke et al., 2021). Research highlights disparities in HPV prevalence and outcomes: women are more frequently diagnosed than men, Black women are disproportionately affected compared to White women, and low- and middle-income individuals experience higher risk than higher-income counterparts (Amboree & Darkoh, 2020). These findings emphasize the importance of targeted health promotion initiatives to prevent HPV in young women (Naqvi & Gale, 2020).
HPV-related health disparities arise from multiple factors, including race, age, sex, income, geographic location, and access to vaccination and screening services (Correl, 2023).
| Factor | Description of Disparity |
|---|---|
| Race | Black women have higher rates of HPV-related cervical cancer than White women. |
| Sex | Men are less likely to seek preventive measures despite being carriers. |
| Income | Low-income households face financial and accessibility barriers to prevention and treatment. |
| Age | Peak HPV infection occurs between 15–25, but cancer can develop up to age 60. |
| Geography | Southern U.S. regions report higher HPV prevalence than northern regions. |
| Healthcare Access | Minority populations often experience bias or limited access to HPV services. |
These disparities affect awareness, access, and adherence to HPV prevention measures, underlining the necessity of culturally sensitive health promotion programs.
A case example involves Maria, a 22-year-old Latina diagnosed with early-stage HPV cervical cancer. Maria experiences emotional, physical, social, and financial challenges related to her condition. To address these challenges, SMART (Specific, Measurable, Achievable, Relevant, and Time-bound) goals were established (White et al., 2020).
| Goal | Intervention | Outcome |
|---|---|---|
| Reduce financial burden by 60% in six months | Enroll in insurance programs and access free community clinics | Economic relief and enhanced treatment adherence |
| Educate on HPV and dispel myths | Attend 3–6 workshops (online and in-person) over 3 months | Increased knowledge and reduced anxiety |
| Improve social support | Join online support groups | Reduced isolation and improved coping with social stigma |
| Enhance emotional well-being | Weekly counseling sessions for 3 months | Improved emotional resilience and mental health |
These goals aim to empower Maria by providing financial, educational, social, and emotional support, aligning with the principles of SMART goal planning. Following participation in workshops and counseling, Maria demonstrated increased confidence, improved coping strategies, and adherence to preventive health behaviors.
This health promotion plan emphasizes the importance of preventing and managing HPV-related cervical cancer. Given the asymptomatic nature of HPV, early intervention through vaccination, regular screening, and education is essential. Implementing SMART goals for patients like Maria supports holistic care, addressing physical, emotional, and social dimensions of health. By combining education, financial assistance, and psychosocial support, individuals can successfully manage HPV risks and improve overall well-being.
Amboree, T. L., & Darkoh, C. (2020). Barriers to human papillomavirus vaccine uptake among racial/ethnic minorities: A systematic review. Journal of Racial and Ethnic Health Disparities. https://doi.org/10.1007/s40615-020-00877-6
Barker, S. L., Maguire, N., Gearing, R. E., Cheung, M., Price, D., Narendorf, S. C., & Buck, D. S. (2021). A community-engaged healthcare model for currently under-served individuals involved in the healthcare system. SSM – Population Health, 15, 100905. https://doi.org/10.1016/j.ssmph.2021.100905
CDC. (2021, January 19). STD Facts – Human PapillomaVirus (HPV). CDC. https://www.cdc.gov/std/hpv/stdfact-hpv.htm
Clarke, M. A., Risley, C., Stewart, M. W., Geisinger, K. R., Hiser, L. M., Morgan, J. C., … & Wentzensen, N. (2021). Age‐specific prevalence of human papillomavirus and abnormal cytology at baseline in a diverse statewide prospective cohort of individuals undergoing cervical cancer screening in Mississippi. Cancer Medicine, 10(23), 8641–8650. https://doi.org/10.1002/cam4.4340
Correl, R. (2023, December 5). How health disparities can impact HPV-related cancers. Verywell Health. https://www.verywellhealth.com/health-disparities-in-hpv-related-cancers-4173225#:~:text=Health%20disparities%20are%20differences%20in
Elflein, J. (2023, August 31). Topic: Human papillomavirus (HPV) in the U.S. Statista. https://www.statista.com/topics/5094/human-papillomavirus-hpv-in-the-us/#topicOverview
Galeshi, M., Shirafkan, H., Yazdani, S., & Motaghi, Z. (2022). Reproductive health needs of Human PapillomaVirus (HPV) positive women: A systematic review. PLOS One, 17(9), e0266819. https://doi.org/10.1371/journal.pone.0266819
Glenn, N. M., Allen Scott, L., Hokanson, T., Gustafson, K., Stoops, M. A., Day, B., & Nykiforuk, C. I. J. (2021). Community intervention strategies to reduce the impact of financial strain and promote financial well-being: A comprehensive rapid review. Global Health Promotion, 28(1), 42–50. https://doi.org/10.1177/1757975920984182
Haldane, V., Chuah, F. L. H., Srivastava, A., Singh, S. R., Koh, G. C. H., Seng, C. K., & Legido-Quigley, H. (2019). Community participation in health services development, implementation, and evaluation: A systematic review of empowerment, health, community, and process outcomes. PLOS One, 14(5). https://doi.org/10.1371/journal.pone.0216112
Khorram-Manesh, A., Dulebenets, M. A., & Goniewicz, K. (2021). Implementing public health strategies—The need for educational initiatives: A systematic review. International Journal of Environmental Research and Public Health, 18(11), 5888. https://doi.org/10.3390/ijerph18115888
Kim, J. J., Simms, K. T., Killen, J., Smith, M. A., Burger, E. A., Sy, S., … & Canfell, K. (2021). Human papillomavirus vaccination for adults aged 30 to 45 years in the United States: A cost-effectiveness analysis. PLOS Medicine, 18(3), e1003534. https://doi.org/10.1371/journal.pmed.1003534
Naqvi, R., & Gale, O. (2020). Preventative health screening community events, a mechanism to target minority ethnic populations in improving primary care utilisation to improve health outcomes. British Journal of General Practice, 70(suppl 1), bjgp20X711005. https://doi.org/10.3399/bjgp20x711005
Siddiqui, S., Morris, A., Ikeda, D. J., Balsari, S., Blanke, L., Pearsall, M., … & Naslund, J. A. (2022). Scaling up community-delivered mental health support and care: A landscape analysis. Frontiers in Public Health, 10. https://doi.org/10.3389/fpubh.2022.992222
Vorsters, A., Bosch, F. X., Poljak, M., Waheed, D.-N., Stanley, M., & Garland, S. M. (2022). HPV prevention and control – The way forward. Preventive Medicine, 156, 106960. https://doi.org/10.1016/j.ypmed.2022.106960
White, N. D., Bautista, V., Lenz, T., & Cosimano, A. (2020). Using the SMART-EST goals in lifestyle medicine prescription. American Journal of Lifestyle Medicine, 14(3), 271–273. https://doi.org/10.1177/1559827620905775
WHO. (2022). Cervical cancer. https://www.who.int/news-room/fact-sheets/detail/cervical-cancer
WHO. (2023, August 23). Human papillomavirus and cancer. https://www.who.int/news-room/fact-sheets/detail/human-papilloma-virus-and-cancer
